Shiong Patrick Soon, Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, Ten Percent Owner at ImmunityBio, holds 649.72M shares in ImmunityBio (Ticker: IBRX), holds 20.38M shares in NantHealth (Ticker: NHIQ), holds 5.11M shares in Tribune Publishing Co (Ticker: TPCO). Most recently, Shiong Patrick Soon Bought ― shares of ImmunityBio on Dec 12, 2024 for an estimated value of 230.88M.
What is the percentage of profitable transactions made by Shiong Patrick Soon?
The percentage of profitable transactions made by Shiong Patrick Soon is 86%.
What is the average return per transaction made by Shiong Patrick Soon?
The average return per transaction made by Shiong Patrick Soon is 32.90%.
What stocks does Shiong Patrick Soon hold?
Shiong Patrick Soon holds: IBRX, TPCO, NHIQ, SRNE, JAKK stocks.
What was Shiong Patrick Soon’s latest transaction?
Shiong Patrick Soon latest transaction was an Informative Buy of $230.88M.
What was Shiong Patrick Soon's most profitable transaction?
Shiong Patrick Soon’s most profitable transaction was an Informative Sell of SRNE stock on June 15, 2016. The return on the trade was 68.10%.
What is Shiong Patrick Soon's role in ImmunityBio?
Shiong Patrick Soon's role in ImmunityBio is Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.